Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
San Francisco VA Medical Center · Momentum Research · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
903
total citations
- FWCI
- 104.11
- Percentile
- 100%
- References
- 45
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Medicine
- Placebo
- Heart failure
- Clinical endpoint
- Blood pressure
- Internal medicine
- Clinical trial
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.